Company intelligence
Chiesi UK
About Chiesi UK
At Chiesi, we’re more than a biopharmaceutical company - we’re a team of people driven by a deep passion to make life better for others. For over 90 years, we’ve been dedicated to developing innovative treatments focussed on respiratory health, rare diseases and specialty care, supporting patients in over 100 countries worldwide. Our purpose is to help patients live the best possible life and to support them every step of the way. We aim to be a force for good - creating lasting, positive change for people and the planet. As a B Corp, our business practices are certified on environmental, social and governance standards. We have an ambitious yet robust plan to become a Net Zero company by 2035. Our UK business was established in 1999 and has grown to a team of around 400 people, based across our head office in Manchester, a research and development centre in Chippenham and a network of field-based teams. We work closely with the NHS and other healthcare organisations across the UK and Ireland to support solutions that aim to improve patient care and outcomes. Our people are our greatest strength, and we take pride in being an outstanding employer, recognised year after year by internationally recognised organisations such as Great Place to Work®. This recognition reflects the shared values that unite us, bringing together people from diverse nationalities and backgrounds to create an environment grounded in authenticity. We are committed to nurturing development and helping our people unlock their full potential at every step. Community guidelines: https://lnkd.in/e4pPzSKJ. UK-CHI-2600216 | April 2026
Verified activity
Signals from Chiesi UK
3 published signals
People
Chiesi UK is recruiting a Head of Communications to join the UK team
Reported by Chiesi UK
Presence & Recognition
Chiesi UK is hosting a virtual event titled True Faces of Rare: From Pledges to Progress on Thursday 17th September 2026.
Reported by Chiesi UK
Presence & Recognition
Chiesi UK is participating in the True Faces of Rare event on 17 September to discuss how organisations can put authentic representation into practice.
Reported by Kamran Iqbal